Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00236392Phase 3Completed
A Phase 3 trial of rabeprazole in non-erosive reflux disease (NERD), sponsored by Janssen Pharmaceutical. Started Oct 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00236392.